Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N, Ruggieri S: Enzymology of NAD + homeostasis in man. Cell Mol Life Sci 2004,61(1):19–34.PubMedCrossRef 28. Houtkooper RH, Canto C, Wanders RJ, Auwerx J: The secret life of NAD+: an old metabolite controlling new metabolic

signaling pathways. Endocr Rev 2010,31(2):194–223.PubMedCrossRef 29. Bogan KL, Brenner C: Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD + precursor vitamins in human nutrition. Annu Rev Nutr 2008, 28:115–130.PubMedCrossRef 30. Burkle A: Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays 2001,23(9):795–806.PubMedCrossRef 31. Michels PA, Avilan L: The NAD + metabolism of Leishmania, notably the IACS-10759 enzyme nicotinamidase involved in NAD + salvage, offers prospects for development of anti-parasite chemotherapy. Mol MK 8931 supplier Microbiol 2011,82(1):4–8.PubMedCrossRef 32. Gallo CM, Smith DL Jr, Smith JS: Nicotinamide clearance by Microbiology inhibitor Pnc1 directly regulates Sir2-mediated silencing and longevity. Mol Cell Biol 2004,24(3):1301–1312.PubMedCentralPubMedCrossRef 33. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA: Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of

yeast sir2 and human SIRT1. J Biol Chem 2002,277(47):45099–45107.PubMedCrossRef 34. Virag L, Szabo C: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev Interleukin-3 receptor 2002,54(3):375–429.PubMedCrossRef 35. Koszalka GW, Vanhooke J, Short SA, Hall WW: Purification and properties of inosine-guanosine phosphorylase from Escherichia coli K-12. J Bacteriol 1988,170(8):3493–3498.PubMedCentralPubMed 36. Seeger C, Poulsen C, Dandanell G: Identification and characterization of genes (xapA, xapB, and xapR) involved in xanthosine catabolism

in Escherichia coli. J Bacteriol 1995,177(19):5506–5516.PubMedCentralPubMed 37. Dandanell G, Szczepanowski RH, Kierdaszuk B, Shugar D, Bochtler M: Escherichia coli purine nucleoside phosphorylase II, the product of the xapA gene. J Mol Biol 2005,348(1):113–125.PubMedCrossRef 38. Wielgus-Kutrowska B, Kulikowska E, Wierzchowski J, Bzowska A, Shugar D: Nicotinamide riboside, an unusual, non-typical, substrate of purified purine-nucleoside phosphorylases. Eur J Biochem 1997,243(1–2):408–414.PubMedCrossRef 39. Pardee AB, Benz EJ Jr, St Peter DA, Krieger JN, Meuth M, Trieshmann HW Jr: Hyperproduction and purification of nicotinamide deamidase, a microconstitutive enzyme of Escherichia coli. J Biol Chem 1971,246(22):6792–6796.PubMed 40. Imsande J: Pathway of diphosphopyridine nucleotide biosynthesis in Escherichia coli. J Biol Chem 1961, 236:1494–1497.PubMed 41. Hammer-Jespersen K, Buxton RS, Hansen TD: A second purine nucleoside phosphorylase in Escherichia coli K-12. II. Properties of xanthosine phosphorylase and its induction by xanthosine. Mol Gen Genet 1980,179(2):341–348.PubMedCrossRef 42.